Growth Investments invests in scalable, high-growth life science companies that have reached, or are approaching the commercial stage and require capital for expansion and acceleration.
We focus on investments in life science tools and diagnostics, MedTech, life science services and healthcare technology.
Our combination of patient capital, deep sector expertise and global network positions us as a long-term partner to companies navigating growth in dynamic and often challenging market environments.
We are an engaged investor and active partner to life science companies with strong fundamentals and differentiated technologies. Our investments focus primarily on life science tools and diagnostics, MedTech, healthcare IT and life science services.
We leverage our scientific insight, operational experience and international network to support management teams as they scale their organisations, expand into new markets and strengthen their platforms. Novo Holdings’ evergreen capital structure enables us to maintain a long-term perspective and support portfolio companies beyond traditional fund cycles.

3
bn
Value of Investment Assets Portfolio
6
Number of portfolio companies
221
m
Deployed in 2025
Search
Meet our team

News
10/1/2025
Novo Holdings Announces Acquisition of Elektrofi by Halozyme

News
07/21/2025
MedGenome raises Series E funding, co-led by Maj Invest and Novo Holdings, to expand access to its genomics offerings in India

News
09/23/2024
Novo Holdings Expands MedTech Portfolio with Investment in Route 92 Medical

News
08/1/2024
Novo Holdings Invests in UK-Listed Oxford Nanopore Technologies